Update: AstraZeneca Aims To Enhance Cancer Care At WCLC And ESMO 2024 Conferences
AstraZeneca shared results from a study showing TROP2 biomarker's predictive value in lung cancer patients treated with datopotamab deruxtecan. This biomarker was measured…